NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population

NCT06419413

RecruitingN/A

Sponsor: AstraZeneca

Conditions: Asthma

Countries: China

A Translational Study to Describe Asthma Patient Clinical Characteristics, Treatment Patterns, Biomarkers and to Identify Phenotypes and Endotypes associated with Differential Outcomes that may Support Future Development of Personalised Treatment Strategies in Chinese Population

Eligibility overview

Sex: ALL

Age: 18 Years to 75 Years

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Age 18 to 75 years of age
* acceptable FEV1 (according to ATS and ERS)
* compliance with study procedures All Asthma Cohorts
* physician diagnosed Asthma greater or equal to 3 months prior to screening visit

Exclusion Criteria:

* history of alcohol or drug abuse within the past year
* pregnant at time of an assessment
* has an altered mental status at the time of informed consent
* receipt marketed or investigational biologic(s) within 3 months or 5 half-lives prior to visit 1, whichever is longer
* history or current upper or lower respiratory infection or symptoms within 2 weeks of baseline assessments
* terminal diseases and/or organ failure or participants otherwise considered not appropriate for the study participation
* Receipt LTRAs or 5-lipoxygenase (5-LO) inhibitors (eg zileuton and montelukast) within 1 month or 5 half-lives prior to baseline, whichever is longer.

Locations (21)

Chengdu, Sichuan, China
Beijing, China
Changsha, China
Dongguan, China
Foshan, China
Guangzhou, China
Hainan, China
Hohhot, China
Huizhou, China
Kunming, China
Nanjing, China
Nanning, China
Shanghai, China
Shenyang, China
Taiyuan, China
Wenzhou, China
Wuhan, China
Xi'an, China
Xuzhou, China
Zhanjiang, China
Zhaoqing, China